Abstract

Veterinary Compounding for Myasthenia Gravis

Author(s): Davidson Gigi S

Issue: Sep/Oct 2008 - Veterinary Compounding

Page(s): 398-401

Download in electronic PDF format for $75

Abstract

Myasthenia gravis is a neuromuscular disease commonly encountered in veterinary medicine. With accurate diagnosis, treatment, and compliant caregivers, the prognosis for remission and a normal life is good. Unfortunately, drugs used to diagnose and treat myasthenia gravis are frequently unavailable due to manufacturer shortages. During these periods, compounding pharmacists can play a valuable role in maintaining a good quality of life for these patients by providing compounded versions of drugs that are commercially unavailable.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2003 Pg. 106-113	Veterinary Transdermal Medications: A to Z Author(s): Davidson Gigi S
Sep/Oct 2008 Pg. 398-401	Veterinary Compounding for Myasthenia Gravis Author(s): Davidson Gigi S
Mar/Apr 2001 Pg. 86-88	The Use of Psychoactive Agents in Veterinary Medicine Author(s): Simpson Barbara S
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2019 Pg. 428-433	The Current Landscape of Veterinary Compounding in the Veterinary Setting Author(s): Gochenauer Alexandria E, Rishniw Mark, Holmes Erin R, Forsythe Lauren R
Sep/Oct 2019 Pg. 422-427	The Current Landscape of Veterinary Compounding in the Pharmacy Setting Author(s): Gochenauer Alexandria E, Holmes Erin R, Barber Katie E, Forsythe Lauren R
Jan/Feb 2004 Pg. 46-48	Basics of Compounding for Disorders of the External Ear Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 357-362	United States Pharmacopeia Convention Standards and Clinical Information for Compounded Medications Used in Veterinary Medicine Author(s): DeVeau Ian
Jul/Aug 2004 Pg. 269-274	Current Topical Treatments in Wound Healing - Part 1 Author(s): Helmke Christopher D
Nov/Dec 2006 Pg. 417-418	Compounding for Veterinary Medicine Author(s): Fields Shannon W
Jul/Aug 1997 Pg. 222-227	Veterinary Compounding: A Bird's Eye View Author(s): Jordan Dinah G
Sep/Oct 2008 Pg. 384-390	Canine Public Servants: Caring for Drug Detection Dogs Author(s): Davidson Gigi S
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
May/Jun 2017 Pg. 234	Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 100-109	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024 Pg. 136	Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 366-369	To Compound or Not to Compound: A Veterinary Transdermal Discussion Author(s): Eichstadt Lauren R, Davidson Gigi S
Sep/Oct 2014 Pg. 411	Ephedrine Sulfate 50-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 233	Phenoxybenzamine Hydrochloride 5-mg Capsules, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 227	Dipyrone 500-mg/mL Injection, Veterinary Author(s): Allen Loyd V Jr